| Identification | Back Directory | [Name]
Acetamide, N-[2-[(5-chloro-2-methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]- | [CAS]
333746-76-2 | [Synonyms]
WAY-299185
MMP-9-IN-7
Acetamide, N-[2-[(5-chloro-2-methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]- | [Molecular Formula]
C16H15ClN4O2S2 | [MOL File]
333746-76-2.mol | [Molecular Weight]
394.9 |
| Hazard Information | Back Directory | [Uses]
MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extracted from patent WO2012162468 (example 59), and can be used for MMP9/MMP13 mediated syndrome research[1]. | [IC 50]
MMP-9: 0.52 μM (IC50) | [References]
[1] Paul Francis Jackson, et al. Thiazol derivatives as pro -matrix metalloproteinase inhibitors. Patent WO2012162468. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|